SE0602549L - Nya formuleringar för behandling av inflammatoriska tillstånd med an stark TH2 komponent - Google Patents

Nya formuleringar för behandling av inflammatoriska tillstånd med an stark TH2 komponent

Info

Publication number
SE0602549L
SE0602549L SE0602549A SE0602549A SE0602549L SE 0602549 L SE0602549 L SE 0602549L SE 0602549 A SE0602549 A SE 0602549A SE 0602549 A SE0602549 A SE 0602549A SE 0602549 L SE0602549 L SE 0602549L
Authority
SE
Sweden
Prior art keywords
inflammatory conditions
strong
treatment
component
new formulations
Prior art date
Application number
SE0602549A
Other languages
English (en)
Other versions
SE532250C2 (sv
Inventor
Lars Hellman
Original Assignee
Theravac Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravac Pharmaceuticals Ab filed Critical Theravac Pharmaceuticals Ab
Priority to SE0602549A priority Critical patent/SE532250C2/sv
Priority to PCT/SE2007/001036 priority patent/WO2008066443A1/en
Publication of SE0602549L publication Critical patent/SE0602549L/sv
Publication of SE532250C2 publication Critical patent/SE532250C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE0602549A 2006-11-28 2006-11-28 Nya formuleringar av IL-33 för behandling av inflammatoriska tillstånd med en stark TH2 komponent genom vaccinering SE532250C2 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0602549A SE532250C2 (sv) 2006-11-28 2006-11-28 Nya formuleringar av IL-33 för behandling av inflammatoriska tillstånd med en stark TH2 komponent genom vaccinering
PCT/SE2007/001036 WO2008066443A1 (en) 2006-11-28 2007-11-26 Il-33 vaccine for the treatment of inflammatory conditions with a strong th2 component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0602549A SE532250C2 (sv) 2006-11-28 2006-11-28 Nya formuleringar av IL-33 för behandling av inflammatoriska tillstånd med en stark TH2 komponent genom vaccinering

Publications (2)

Publication Number Publication Date
SE0602549L true SE0602549L (sv) 2008-05-29
SE532250C2 SE532250C2 (sv) 2009-11-24

Family

ID=39468147

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0602549A SE532250C2 (sv) 2006-11-28 2006-11-28 Nya formuleringar av IL-33 för behandling av inflammatoriska tillstånd med en stark TH2 komponent genom vaccinering

Country Status (2)

Country Link
SE (1) SE532250C2 (sv)
WO (1) WO2008066443A1 (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111012905A (zh) * 2013-10-07 2020-04-17 宾夕法尼亚大学理事会 具有作为佐剂的白介素-33的疫苗

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20170910A1 (es) 2014-11-10 2017-07-12 Genentech Inc Anticuerpos anti-interleucina-33 y sus usos
CN107109494B (zh) 2014-11-10 2023-10-27 豪夫迈·罗氏有限公司 Il-33介导型疾病的治疗方法和诊断方法
CN115605507A (zh) 2020-03-13 2023-01-13 基因泰克公司（Us） 抗白介素-33抗体及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846486B1 (en) * 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
NZ549040A (en) * 2004-02-17 2009-07-31 Schering Corp Use for interleukin-33 (IL33) and the IL-33 receptor complex

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111012905A (zh) * 2013-10-07 2020-04-17 宾夕法尼亚大学理事会 具有作为佐剂的白介素-33的疫苗
CN111012905B (zh) * 2013-10-07 2023-12-22 宾夕法尼亚大学理事会 具有作为佐剂的白介素-33的疫苗

Also Published As

Publication number Publication date
SE532250C2 (sv) 2009-11-24
WO2008066443A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
NZ702458A (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof
TN2012000512A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
WO2011113013A3 (en) Methods and compositions for treating viral or virally-induced conditions
BR112013023280A2 (pt) uso de 3-(5-amino-2-metil-4-oxoquinazolina-3(4h)-il)-piperidina-2,6-diona em tratamento de doenças inflamatórias e relacionadas ao sistema imune
MX370565B (es) Miembros de la familia tnf modificados dirigidos.
MX2015015234A (es) Composiciones y metodos para modular la expresion de la apolipoproteina (a).
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
MX346224B (es) Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias.
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
UY30794A1 (es) Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinic0
EA201171043A1 (ru) Композиции и способы длительной терапии с применением аминопиридинов
MX2012000949A (es) Terapias de combinacion con moduladores de ck2.
GB201213267D0 (en) Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
MX2012009718A (es) Material biodegradable que contiene silicio para terapia antiinflamatoria.
SMT201600190B (it) Uso di streptococcus salivarius nel trattamento di infezioni croniche dell'apparato respiratorio
TN2011000653A1 (en) Pharmaceutical compositions and solid forms
SE0602549L (sv) Nya formuleringar för behandling av inflammatoriska tillstånd med an stark TH2 komponent
UY33219A (es) Cetoenoles cíclicos para terapias
BR112012013199A8 (pt) Composto, composição farmacêutica, e , uso de um composto
EA202091356A1 (ru) A2a АНТАГОНИСТЫ КАК УСИЛИТЕЛИ КОГНИТИВНОЙ И МОТОРНОЙ ФУНКЦИЙ
EP2099488A4 (en) TSLP VACCINE FOR THE TREATMENT OF TH2-INDUCED INFLAMMATORY DISORDERS
UA111520C2 (uk) [1,2,4]триазолопіридини і їх застосування як інгібіторів фосфодіестерази
RU2010141064A (ru) Способ лечения папилломавирусных инфекций, реализуемый через индукцию интерлейкина - 18
BR112012000410B8 (pt) uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica